Cancer Policy Supreme Court rejects pharma challenges against CMS drug price negotiating powers May 22, 2026Vol.52 No.20By Sara Willa Ernst
Cancer Policy DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions May 15, 2026Vol.52 No.19By Sara Willa Ernst
Cancer Policy ACCC and cancer community partners issue statement on U.S. drug shortages, urge action May 15, 2026Vol.52 No.19
Cancer Policy Trump changes pick for Surgeon General, nominating Nicole Saphier May 08, 2026Vol.52 No.18By Claire Marie Porter
Cancer Policy Katherine Szarama steps in as CBER acting director, replacing Prasad May 08, 2026Vol.52 No.18By Claire Marie Porter
Cancer Policy CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show May 01, 2026Vol.52 No.17By Claire Marie Porter
Cancer Policy Radiation oncologists urge lawmakers to act as Medicare cuts and private payer tactics push cancer clinics toward closing May 01, 2026Vol.52 No.17
Cancer Policy Kennedy hints at intended USPSTF reforms at Senate Finance Committee hearing April 24, 2026Vol.52 No.16By Claire Marie Porter
Cancer Policy Senators press Kennedy to release details on Most Favored Nation drug deals April 24, 2026Vol.52 No.16By Claire Marie Porter
Cancer Policy Former deputy surgeon general Erica Schwartz nominated as CDC director April 24, 2026Vol.52 No.16By Claire Marie Porter
